Deciphera Pharmaceuticals (DCPH) reported Q4 EPS of ($0.60), $0.03 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $36.35 million versus the consensus estimate of $35.67 million.
Deciphera Pharmaceuticals (DCPH) reported Q4 EPS of ($0.60), $0.03 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $36.35 million versus the consensus estimate of $35.67 million.